We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
Cap. Flow
-$786M
Cap. Flow %
-52.7%
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Consumer Discretionary 3.94%
3 Healthcare 3.91%
4 Communication Services 2.7%
5 Financials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNB icon
776
FNB Corp
FNB
$6.8B
$45K ﹤0.01%
6,170
+121
+2% +$1.28K
MRNA icon
777
CALL
Moderna
MRNA
$24.2B
$45K ﹤0.01%
+1,500
New +$34.5K
OI icon
778
O-I Glass
OI
$1.1B
$45K ﹤0.01%
+6,355
New +$69.6K
AVTA
779
DELISTED
Avantax, Inc. Common Stock
AVTA
$45K ﹤0.01%
+3,718
New +$71.7K
AR icon
780
Antero Resources
AR
$11.6B
$44K ﹤0.01%
61,268
-6,433
-10% -$10.8K
EXEL icon
781
Exelixis
EXEL
$12.7B
$44K ﹤0.01%
+2,534
New +$46.4K
KEYS icon
782
Keysight
KEYS
$58.7B
$44K ﹤0.01%
521
-3,253
-86% -$309K
ROST icon
783
Ross Stores
ROST
$80.8B
$44K ﹤0.01%
504
+1
+0.2% +$107
TLRA
784
DELISTED
Telaria, Inc.
TLRA
$44K ﹤0.01%
7,400
-3,383
-31% -$33.5K
ACGL icon
785
Arch Capital
ACGL
$33.5B
$43K ﹤0.01%
1,509
+788
+109% +$31.9K
ANIK icon
786
Anika Therapeutics
ANIK
$284M
$43K ﹤0.01%
1,490
-2,332
-61% -$94.3K
ATH
787
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$43K ﹤0.01%
+1,726
New +$68.7K
DSPG
788
DELISTED
DSP Group Inc
DSPG
$43K ﹤0.01%
3,181
-3,824
-55% -$54.8K
GRUB
789
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$43K ﹤0.01%
531
-36,370
-99% -$3.58M
LNTH icon
790
Lantheus
LNTH
$6.57B
$42K ﹤0.01%
3,309
+2,696
+440% +$43.1K
MIDD icon
791
Middleby
MIDD
$5.43B
$42K ﹤0.01%
741
+284
+62% +$27.8K
SPLK
792
DELISTED
Splunk Inc
SPLK
$42K ﹤0.01%
336
-631
-65% -$92.8K
TCO
793
PUT
DELISTED
Taubman Centers Inc.
TCO
$42K ﹤0.01%
+1,000
New +$41.7K
AMTD
794
DELISTED
TD Ameritrade Holding Corp
AMTD
$42K ﹤0.01%
+1,206
New +$52.5K
AMCX icon
795
AMC Global Media
AMCX
$486M
$41K ﹤0.01%
1,703
-4,151
-71% -$141K
AVNT icon
796
Avient
AVNT
$4.17B
$41K ﹤0.01%
2,159
+761
+54% +$21.3K
AXSM icon
797
PUT
Axsome Therapeutics
AXSM
$11.1B
$41K ﹤0.01%
700
+300
+75% +$24.4K
KIM icon
798
Kimco Realty
KIM
$16.1B
$41K ﹤0.01%
+4,189
New +$72K
UMC icon
799
United Microelectronic
UMC
$47.5B
$41K ﹤0.01%
18,957
+782
+4% +$1.97K
FLG
800
Flagstar Bank National Association
FLG
$5.89B
$41K ﹤0.01%
1,442
-7,272
-83% -$242K

Similar funds

Prelude Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.

  • Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
  • Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
  • Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
  • Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
  • Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
  • Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
  • Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.